Align Technology, Inc. Profile Avatar - Palmy Investing

Align Technology, Inc.

Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It oper…
Medical - Devices
US, Tempe [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 0% Bad
Profitability n.A. n.A.
Fin. Growth 50% Balanced
Leverage & Liquidity 17% Weak
Per Share Metrics 67% Positive
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA 7.31 124.49 116.02
Graham Fair Price -5.69 39.65 42.04
PEG -70.61 -3.91 13.30
Price/Book 11.86 6.39 5.71
Price/Cash Flow -19.04 1245.38 1538.31
Prices/Earnings 36.79 57.20 41.82
Price/Sales 11.12 24.09 21.68
Price/FCF -19.04 1245.38 1538.31
Naive Interpretation member
01 - Valuation · Bad
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin 0.24 0.71 0.70
Operating Margin -20.31 0.15 0.19
ROA -16.30 0.02 0.02
ROE 0.03 0.03 -18.22
ROIC 0.04 0.03 -25.76
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ 0.30 -0.02 1824.13
Dividends QOQ 0.00 0.00 0.00
EBIT QOQ 0.12 -0.17 46.72
EPS QOQ 0.03 -0.15 365.37
FCF QOQ -0.95 0.43 -54.60
Revenue QOQ < 0.005 0.04 1071.26
Naive Interpretation member
03 - Financial Growth · Balanced
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 94.17 85.69 -9.01
Days Sales Outstanding (DSO) 84.99 104.46 22.91
Inventory Turnover 0.96 1.05 9.90
Debt/Capitalization 0.03 0.03 -3.48
Quick Ratio 0.91 1.02 11.98
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 47.96 50.01 4.29
Cash 12.85 11.96 -6.94
Capex -0.44 -0.12 71.76
Free Cash Flow 0.18 0.26 44.10
Revenue 12.64 13.27 4.99
Naive Interpretation member
05 - Per Share Metrics · Positive
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 1.18 1.23 3.52
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -4.90 -3.95 19.33
Naive Interpretation Member
06 - Financial Health · Weak
End of ALGN's Analysis
CIK: 1097149 CUSIP: 016255101 ISIN: US0162551016 LEI: - UEI: -
Secondary Listings